DIN 02456915 — COPAXONE 40 MG
COPAXONE is a solution of Glatiramer acetate marketed by TEVA CANADA LIMITED. The full Glatiramer acetate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456915
- Brand name
- COPAXONE
- Active ingredient
- Glatiramer acetate
- Strength
- 40 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Immunomodulator
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Glatiramer acetate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02245619 | COPAXONE | 20 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02460661 | GLATECT | 20 MG | SOLUTION | PHARMASCIENCE INC | MARKETED |
| 02541440 | GLATIRAMER ACETATE INJECTION | 20 MG | SOLUTION | MYLAN PHARMACEUTICALS ULC | MARKETED |